Caring Brands, Inc. (NASDAQ:CABR – Get Free Report) saw a significant drop in short interest in the month of October. As of October 15th, there was short interest totaling 2,863 shares, a drop of 55.5% from the September 30th total of 6,427 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average daily trading volume, of 35,362 shares, the days-to-cover ratio is currently 0.1 days.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in Caring Brands stock. Susquehanna International Group LLP purchased a new position in shares of Caring Brands, Inc. (NASDAQ:CABR – Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 20,771 shares of the company’s stock, valued at approximately $26,000. Susquehanna International Group LLP owned 0.20% of Caring Brands at the end of the most recent quarter.
Analyst Ratings Changes
Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Caring Brands in a research note on Tuesday, September 8th. One investment analyst has rated the stock with a Sell rating. Based on data from MarketBeat, Caring Brands has an average rating of “Sell”.
View Our Latest Research Report on Caring Brands
Caring Brands Trading Up 5.6%
Caring Brands stock traded up $0.06 during midday trading on Friday, hitting $1.13. 101,179 shares of the stock were exchanged, compared to its average volume of 33,897. The stock’s 50-day simple moving average is $1.22 and its 200 day simple moving average is $1.15. Caring Brands has a fifty-two week low of $0.71 and a fifty-two week high of $5.35. The stock has a market capitalization of $11.83 million and a price-to-earnings ratio of -1.53.
Caring Brands (NASDAQ:CABR – Get Free Report) last posted its earnings results on Thursday, August 13th. The company reported ($0.10) earnings per share for the quarter.
Caring Brands Company Profile
We are a wellness consumer products company. We offer several over-the-counter, or (OTC) and cosmetic, consumer products. Our method of operation is to ensure that (1) the mechanism of action of all products is established, (2) efficacy is determined through controlled clinical trials, (3) products are protected by issued and filed patents, and (4) products have acceptable commercial stability. Prior to its Q3 2022 commercial launch in India as a treatment for vitiligo and psoriasis, Photocil was briefly launched in the United States markets from December 2022 until February 2023, however, was subsequently removed from the market due to insufficient sales resulting from the lack of a dedicated sales and marketing team.
See Also
- Five stocks we like better than Caring Brands
- Starbucks Says Its Turnaround Is Done—The Numbers Make a Strong Case (With 1 Catch)
- 3 Robotics ETFs, 3 Different Ways to Bet on Humanoid Robots
- Can Microsoft Turn a Leaner Workforce and Record AI Spending Into Bigger Profits?
- Why JFrog Could Be the Software Infrastructure Company to Beat in the AI Boom
Receive News & Ratings for Caring Brands Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Caring Brands and related companies with MarketBeat.com's FREE daily email newsletter.
